Project Grant HT94252310425
Award Date 9/1/23
Completion Date 8/31/26
Dollars Obligated $651K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Johns Hopkins University a $1.553 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective October 1, 2025, through September 30, 2028. The award supports research investigating the impact of breast tissue microbiota on breast cancer progression, conducted at the institution's Baltimore, Maryland facility. This three-year research initiative represents DHA's investment in...
- The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...
- Federal Grant Award Summary The Johns Hopkins University received a $1.55M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 30, 2025, through September 29, 2028. The grant supports research focused on early detection of endometrial carcinoma through cell enrichment and flow cytometry methodologies. This three-year initiative aims to develop and advance diagnostic techniques that leverage cell...
- Federal Grant Award Summary The Johns Hopkins University received a $465,750 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025 through June 30, 2027. The award supports research investigating estrogen receptor mutations as a novel biomarker for response to endocrine therapy in ovarian cancer. This research contributes to the DHA's mission to transform healthcare for service members and the...
- Federal Grant Award Summary The Johns Hopkins University received a $232,878 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2025 through May 31, 2027. The award supports research exploring the role of epitranscriptomics in the evolution of neuroendocrine prostate cancer, conducted at the institution's Baltimore, Maryland facility. This research initiative contributes to the DHA's broader mission of...
- Federal Project Grant Award Summary The Johns Hopkins University received a $1,349,813 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The award supports research on noninvasive approaches for lung cancer detection, monitoring, and interception. This research initiative aligns with the Defense Health Agency's mission to transform healthcare for military service...
- Federal Grant Award Summary The Johns Hopkins University received a $1.55M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded July 1, 2025, with a completion date of June 30, 2028. The award supports noninvasive machine learning analyses of cell-free DNA (cfDNA) fragmentomes for early detection of liver cancer. This research project falls within the DHA's mandate to advance biomedical innovation addressing...
- Summary of Federal Project Grant Award The Johns Hopkins University was awarded $459,932 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2025 through May 31, 2027. The project, titled "Interrogating Cribriform Lesions to Uncover Mechanisms of Prostate Cancer Aggressiveness and Metastasis," will be conducted at the institution's Baltimore, Maryland facility. This award supports hypothesis-driven biomedical...
- The Johns Hopkins University was awarded a $974,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, spanning August 1, 2023 to July 31, 2026, will support research to engineer an effective combination therapy of car T cells and regulatory T cells to control rejection of vascularized composite allografts. This research aims to develop medical solutions for the battlefield and transform healthcare for...
- The Johns Hopkins University was awarded a $1,170,746 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to investigate the polyaneuploid cancer cell state and its role in mediating multitherapy resistance in cancer. The three-year award, effective August 15, 2022 through August 14, 2025, will support research into transforming healthcare for service members and the public through innovative biomedical...